Quest Diagnostics Inc (NYSE:DGX) over-valued by 11%
Website | https://www.questdiagnostics.com/ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $15,887,460,352 |
Beta | 1.033645 |
Average Volume | $1,256,940 |
Last Dividend | 2.3% |
Price on Oct 21, 2022 | $138.96 |
Autochartist™ Valuation | $123.28 |
Conclusion |
11% over-valued |
Download Report |